South Korean firm LOTTE has agreed to purchase Bristol Myers Squibb’s manufacturing facility in East Syracuse, New...
GenScript ProBio, a global CDMO company from GenScript Biotech Corporation, has announced the opening of a legal entity ...
The birth of a universal antiviral drug with a mechanism applicable to all viral infections is approaching. This antivir...
Dr Dame Jenny Harries, Chief Executive of the UK Health Security Agency (UKHSA), has signed a Memorandum of Understandin...
The intake of multiple drugs can result in adverse health effects due to unexpected drug-drug interactions (DDIs). Now, ...
A group of researchers at Korea University have developed an electronic medical system that can be inserted into de...
South Korea-based SK bioscience and GSK have announced submission of a biologics license application for SKYCovione a re...
Daewoong Pharmaceutical has signed a joint research and development agreement with UCI Therapeutics (CEO Sooyoung Jung),...
GC Biopharma, based in South Korea, and Canadian firm Acuitas Therapeutics, a company focused on developing lipid nanopa...
Korea's PharmAbcine Inc., a clinical-stage biotech company focusing on the development of next-generation antibody thera...
Seegene Inc., South Korea's leading molecular diagnostics (MDx) company, has announced the development of the ...
Adge Pharmaceuticals has entered into a license agreement with South Korea-based Cyan Bio, Inc. Cyan will receive exclus...
South Korea-based startup Vuno has signed a research agreement with Mayo Clinic in the US. The research agreement, which...
A research group led by Professor Young Min Song of the Gwangju Institute of Science and Technology in Korea h...
South Korea's LG Chem has announced that its Chinese counterpart TransThera Sciences received the IND clearance fro...
GC corp., the holding (system) company for GC group in South Korea with major operating companies across healthcare se...
China's GeneQuantum Healthcare, a company specializing in site-specific bioconjugation for next generation biotherapeuti...
Bridge Biotherapeutics, a South Korean clinical-stage biotechnology company focused on developing novel drugs for fibros...
